RTP Startups | Powered by Eureka Biomed Collective

SOP Spotlight: Internal Communications Workflow One of the most underestimated quality risks in early-stage life sciences companies? Internal communication breakdowns. Teams assume alignment. Quality signals get missed. Decisions go undocumented. And months later, a compliance gap surfaces that could have been caught on day one. Our Internal Communications Workflow SOP gives your team a clear, repeatable map: - How to route quality signals across functions - When and how to escalate issues - How to stay aligned from channel mapping through continuous improvement - Compliance anchoring to ISO 13485:2016 10 structured steps. Designed for small teams. Built to scale. This is one of the 10+ workflow SOPs included in our Pre-Launch QMS package. Curious what else is inside? Drop a comment or book a free 30-minute consultation — we'll walk you through the full package. #QMS #SOP #QualityManagement #LifeSciences #Biotech #Medtech #RegulatoryCompliance #ISO13485 #PreLaunch

Regulatory confusion is costing founders real time. 🧭 Biotech, MedTech, Diagnostics. Each path looks different, and most founders don't know which one they're on. We built the Regulatory Roadmap Series to change that. From product definition to post-market planning, we're breaking down every stage, by product type, with the checkpoints and pitfalls that actually matter. You're not alone in this. There's a clear path forward. Follow along. Or book a free consult to map yours today.

Introducing our Pre-Launch QMS — built for emerging life sciences companies who are ready to get serious about quality, without the enterprise price tag. Here's what's different: It's AI-native. We've reimagined SOP development from the ground up, making documentation faster, smarter, and more practical for small teams. It's designed for where you are. Most QMS systems are built for large, established organizations. This one is built for companies in the pre-launch and early development phase, right when you need it most. It's customizable. Every package can include add-on consulting time, training sessions, or be tailored to your specific product type and development stage. It's your affordable first step before investing in a full enterprise QMS system. We're finalizing pricing, but we want to start a conversation now. Book a free 30-minute consultation and let's talk about what you actually need. Drop a comment or DM us, we'd love to connect. #PreLaunchQMS #QualityManagement #LifeSciences #Biotech #Medtech #AIinHealthcare #StartupFounder

Regulatory confusion is costing founders real time. Most early-stage teams don't know where to start. They pick the wrong pathway, miss key classifications, and build evidence plans too late. This roadmap changes that. Biotech. MedTech. Diagnostics. Six steps, a founder checklist, and the pitfalls we see most often. 🗺️ Save this. Share it with your team. Ready to map your specific pathway? Book a complimentary strategy call with Eureka Biomed Collective at eurekabiomed.com

Most early-stage biotech and medtech founders are building something remarkable. But when the question comes up — "Do we have a quality management system?" — the answer is usually one of these: "We're using a spreadsheet." "We know we need one, but haven't had time." "We looked at enterprise QMS options and they were way out of budget." Here's the reality: there is a gap between "we know quality matters" and "we're ready for a full enterprise QMS system." And most companies spend too long in that gap, unprepared when it matters most. That's exactly what we set out to solve. We've been building something new at Eureka Biomed Collective and we're ready to share more this week. Stay tuned. #QMS #LifeSciences #Biotech #Medtech #StartupFounder #QualityManagement #Regulatory

Regulatory confusion is costing founders real time. 🧭 Biotech, MedTech, Diagnostics. Each path looks different. Most founders don't know where to start. That's not a failure. It's just a gap no one filled clearly. We built the Regulatory Roadmap Series for exactly this moment. Practical checkpoints. Common pitfalls. A founder-friendly path forward. Save this post. Share it with your team. Want the full checklist for your product type? Drop a comment or send us a message.

TODAY: The FREE America's Seed Fund Week virtual event starts at 12:30pm ET! ✅ Learn about the Small Business Innovation Research and Small Business Technology Transfer programs ✅ Get matched with federal agencies ✅ Meet program directors And more! Register now: http://bit.ly/2026ASFWeek #SeedTheFuture

Looking forward this event! Who is coming ?

I’m offering 3 free life science commercialization reviews to validate a new research tool! I’m building a new life science commercialization research tool designed to help founders and investors evaluate early-stage opportunities in biotech, pharma, diagnostics, medical devices, digital health, research tools, and related sectors. The goal is simple: make it easier to assess whether an idea has real commercial potential before too much time and capital are committed. This tool is designed to help evaluate: -the problem and unmet need -customer and buyer dynamics -market opportunity -competitive landscape -regulatory and reimbursement considerations -commercialization pathways -investor-readiness gaps -evidence gaps that still need to be validated Right now, I’m looking for 3 business ideas to evaluate at no cost as part of a live validation phase. In exchange, participants will: -complete an intake form -share non-confidential background information about the idea -allow me to use the project to test and improve the tool In return, I’ll provide research-based commercialization insights and I’ll be happy to share broader lessons learned from the experiment once this pilot phase is complete. A few important notes: -Please share general, non-confidential information only -Do not include trade secrets, unpublished IP details, proprietary technical data, or anything you would not want broadly disclosed -The more context you can provide, the better the analysis will be If you’re a founder exploring a new opportunity, or an investor looking at an early concept, and you’d like to participate, fill out the intake form and I’ll get started. Pilot disclaimer: This no-cost evaluation is part of a tool validation exercise for informational and educational purposes only. Submission of information does not create a legal, investment, regulatory, fiduciary, or other advisory relationship, and no confidentiality obligation is created unless separately agreed in writing. Please do not submit trade secrets, proprietary IP, or other confidential information. Any insights shared are preliminary, based only on the information provided and available evidence at the time of review, and should not be relied on as legal, regulatory, investment, or financial advice. If you’d like, I can drop the intake form link in the comments or send it directly.

🚨 10 days to go. 🚨 (not an April's fools joke) This is your shot 👇 💰 $135K in prizes 🎤 Pitch live to investors 🤝 Build real connections that matter Open to: Agtech & Foodtech Healthtech & Biotech Talent & Productivity Tech Emerging Tech 📍 Birmingham, AL | June 24 If you’re building something real—don’t sit this one out. ⏳ Deadline: April 10 Apply now: https://lnkd.in/eF4-bWRp #startups #venturecapital #founders #pitchcompetition #innovation #SlossTech Please share with your networks: Preet Mankad, Michelle Murdough, Mary Wallace Hannon, Jim Roberts, NC IDEA, Krista Covey, Juan Garzón, Rachael Meleney Newberry, Mike Carnes, Andrew Schwab, Alex Gray, Peter Marsh, JP Maloney, Jeffrey Kaplan, Rebekah Gregg, CED (Center for Entrepreneurial Development), Jenn Summe, GrepBeat, Amy Bastian